Medication remains the cornerstone treatment for mental illness. Cognition is one of the strongest predictors of non-adherence. The aim of this preliminary investigation was to examine the association between the Large Allen Cognitive Level Screen (LACLS) and medication adherence among a small sample of mental health service users to determine whether the LACLS has potential as a screening tool for capacity to manage medication regimens.
Method:
Demographic and clinical information was collected from a small sample of people who had recently accessed community mental health services. Participants then completed the LACLS and the Medication Adherence Rating Scale (MARS) at a single time point. The strength of association between the LACLS and MARS was examined using Spearman rank-order correlation.
Results:
A strong positive correlation between the LACLS and medication adherence (r = 0.71, p = 0.01) was evident. No participants reported the use of medication aids despite evidence of impaired cognitive functioning.
Conclusion:
This investigation has provided the first empirical evidence indicating that the LACLS may have utility as a screening instrument for capacity to manage medication adherence among this population. While promising, this finding should be interpreted with caveats given its preliminary nature.
Alfred Psychiatry Research Centre, The (n.d.) Medication Adherence Rating Scale (MARS). Prahran: The Alfred PRC.
2.
AllenCKEarhartCBlueT (1992) Occupational therapy treatment goals for the physically and cognitively disabled. Bethesda, MD: American Occupational Therapy Association.
3.
AllenCKAustinSLDavidSKEarhartCAMcCraithDBRiska-WilliamsL (2007) Manual for the Allen Cognitive Level Screen-5 (ACLS-5) and Large Allen Cognitive Level Screen-5 (LACLS-5). Camarillo: ACLS and LACLS Committee.
4.
American Occupational Therapy Association (2000) OT and community mental health. Available at: www.aota.org/consumers Accessed 07.09.12.
5.
Ascher-SvanumHFariesDEZhuBErnstFRSwartzMSSwansonJW (2006) Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care. Journal of Clinical Psychiatry, 67(3), 453–60.
6.
AubinGCIEC (2009) Use of the Perceive, Recall, Plan and Perform System of Task Analysis for persons with schizophrenia: A preliminary study. Australian Occupational Therapy Journal, 56(3), 189–99.
7.
ByerlyMJNakoneznyPARushAJ (2008) The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder. Schizophrenia Research, 100(1–3), 60–69.
8.
ClatworthyJBowskillRRankTParhamRHorneR (2007) Adherence to medication in bipolar disorder: A qualitative study exploring the role of patients' beliefs about the condition and its treatment. Bipolar Disorders, 9(6), 656–64.
9.
CorrissDJSmithTEHullJWLimRWPrattSIRomanelliS (1999) Interactive risk factors for treatment adherence in a chronic psychotic disorders population. Psychiatry Research, 89(3), 269–74.
10.
CramerJARosenheckR (1998) Compliance with medication regimens for mental and physical disorders. Psychiatric Services, 49(2), 196–201.
11.
CroweMWilsonLInderM (2011) Patients' reports of the factors influencing medication adherence in bipolar disorder — an integrative review of the literature. International Journal of Nursing Studies, 48(7), 894–903.
12.
Dunbar-JacobJMortimer-StephensMK (2001) Treatment adherence in chronic disease. Journal of Clinical Epidemiology, 54(12, Suppl. 1), S57–S60.
13.
DuncanEA (2008) Cognition and cognitive approaches in occupational therapy. In: CreekJLougherL, eds. Occupational therapy and mental health. 4th ed.Philadelphia: Elsevier.
14.
FentonWSBlylerCRHeinssenRK (1997) Determinants of medication compliance in schizophrenia: Empirical and clinical findings. Schizophrenia Bulletin, 23(4), 637–51.
15.
FialkoLGaretyPAKuipersEDunnGBebbingtonPEFowlerDFreemanD (2008) A large-scale validation study of the Medication Adherence Rating Scale (MARS). Schizophrenia Research, 100(1–3), 53–59.
16.
GrayRWhiteJSchulzMAbderhaldenC (2010) Enhancing medication adherence in people with schizophrenia: An international programme of research. International Journal of Mental Health Nursing, 19(1), 36–44.
17.
GreenMFKernRSBraffDLMintzJ (2000) Neurocognitive deficits and functional outcome in schizophrenia: Are we measuring the ‘right stuff’?Schizophrenia Bulletin, 26(1), 119–36.
18.
HoganTPAwadAGEastwoodR (1983) A self-report scale predictive of drug compliance in schizophrenics: Reliability and discriminative validity. Psychological Medicine, 13(01), 177–83.
19.
JesteSDPattersonTLPalmerBWDolderCRGoldmanSJesteDV (2003) Cognitive predictors of medication adherence among middle-aged and older outpatients with schizophrenia. Schizophrenia Research, 63(1–2), 49–58.
20.
KehrbergKLKuskowskiMAMortimerJAShobergTD (1992) Validating the use of an enlarged, easier-to-see Allen Cognitive Level Test in geriatrics. Physical and Occupational Therapy in Geriatrics, 10(3), 1–14.
21.
LecomteTSpidelALeclercCMacEwanGWGreavesCBentallRP (2008) Predictors and profiles of treatment non-adherence and engagement in services problems in early psychosis. Schizophrenia Research, 102(1–3), 295–302.
22.
LeeM-SLeeH-YKangS-GYangJAhnHRheeMKoYHJoeSHJungIKKimS-H (2010) Variables influencing antidepressant medication adherence for treating outpatients with depressive disorders. Journal of Affective Disorders, 123(1–3), 216–21.
McCraithDBAustinSLEarhartCA (2011) The Cognitive Disabilities Model in 2011. In: KatzN, ed. Cognition, occupation, and participation across the life span: Neuroscience, neurorehabilitation, and models of intervention in occupational therapy. 3rd ed.White Plains, MD: American Occupational Therapy Association, 385–91.
25.
MooreDS (1978) An occupational therapy evaluation of sensorimotor cognition: Initial reliability, validity, and descriptive data for hospitalized schizophrenic adults. Unpublished Master's thesis. Los Angeles: University of Southern California.
26.
MoriskyDESGreenLWDLevineDMMD (1986) Concurrent and predictive validity of a self-reported measure of medication adherence. Medical Care, 24(1), 67–74.
27.
MoritzSFerahliSNaberD (2004) Memory and attention performance in psychiatric patients: Lack of correspondence between clinician-rated and patient-rated functioning with neuropsychological test results. Journal of the International Neuropsychological Society, 10(04), 623–33.
28.
PrimožičSTavčarRAvbeljMDernovšekMZOblakMR (2012) Specific cognitive abilities are associated with diabetes self-management behavior among patients with type 2 diabetes. Diabetes Research and Clinical Practice, 95(1), 48–54.
29.
RobertsM (2008) Life skills. In: CreekJLougherL, eds. Occupational therapy and mental health. 4th ed.Philadelphia: Elsevier.
30.
Royal Australian and New Zealand College of Psychiatrists (2005) Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders. Australian and New Zealand Journal of Psychiatry, 39(1–2), 1–30.
31.
SajatovicMIgnacioRVWestJACassidyKASafaviRKilbourneAMBlowFC (2009) Predictors of nonadherence among individuals with bipolar disorder receiving treatment in a community mental health clinic. Comprehensive Psychiatry, 50(2), 100–07.
32.
SolomonTHalkitisP (2008) Cognitive executive functioning in relation to HIV medication adherence among gay, bisexual, and other men who have sex with men. AIDS and Behavior, 12(1), 68–77.
ThompsonKKulkarniJSergejewAA (2000) Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophrenia Research, 42(3), 241–47.
35.
TownsendL (2009) How effective are interventions to enhance adherence to psychiatric medications? Practice implications for social workers working with adults diagnosed with severe mental illness. Journal of Human Behavior in the Social Environment, 19(5), 512–30.
36.
VelliganDITrueJELeftonRSMooreTCFloresCV (1995) Validity of the Allen Cognitive Levels Assessment: A tri-ethnic comparison. Psychiatry Research, 56(2), 101–09.
37.
VelliganDIBow-ThomasCCMahurinRMillerADassoriAErdelyF (1998) Concurrent and predictive validity of the Allen Cognitive Levels Assessment. Psychiatry Research, 80(3), 287–98.
38.
WilliamsPThayerJ (2009) Executive functioning and health: Introduction to the special series. Annals of Behavioral Medicine, 37(2), 101–05.
39.
ZeberJMillerACopelandLMcCarthyJZivinKValensteinMGreenwaldDKilbourneA (2011) Medication adherence, ethnicity, and the influence of multiple psychosocial and financial barriers. Administration and Policy in Mental Health and Mental Health Services Research, 38(2), 86–95.
